Advanced search
Publication Cover
Journal of Chemotherapy Volume 26, 2014 - Issue 3
Submit an article Journal homepage
151
Views
10
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

S-1 plus oxaliplatin vs. S-1 as first-line treatment in patients with previously untreated advanced gastric cancer: a randomized phase II study

Yiming LuDepartment of AnesthesiologyGuizhou Cancer Hospital, Guiyang550004, PR China
,
Zanchao LiuThe Shijiazhuang Second Hospital of Hebei Province, Shijiazhuang050051, PR China
&
Jun ZhangDepartment of PathologyGuiyang Medical University, Guiyang550004, PR ChinaCorrespondence[email protected]
Pages 159-164 | Published online: 06 Dec 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lok Lam Ngai, Emil ter Veer, Héctor G. van den Boorn, E. Hugo van Herk, Jessy Joy van Kleef, Martijn G. H. van Oijen & Hanneke W. M. van Laarhoven. (2019) TOXview: a novel graphical presentation of cancer treatment toxicity profiles. Acta Oncologica 58:8, pages 1138-1148.
Read now

Articles from other publishers (9)

Long Feng, Lei Shao, Shuangshuang Sun, Chengwu Zhang & Baojia Cai. (2023) Analysis of the efficacy and influencing factors of preoperative P‐SOX neoadjuvant chemotherapy regimen for progressive gastric cancer—construction of a clinical prediction model. Cancer Medicine 12:12, pages 13031-13040.
Crossref
Zhichao Jiang, Aiping Zhou, Yongkun Sun & Wen Zhang. (2022) Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study. BMC Cancer 22:1.
Crossref
Emil ter Veer, Jessy Joy van Kleef, Sandor Schokker, Stephanie O. van der Woude, Marety Laarman, Nadia Haj Mohammad, Mirjam A.G. Sprangers, Martijn G.H. van Oijen & Hanneke W.M. van Laarhoven. (2018) Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis. European Journal of Cancer 103, pages 214-226.
Crossref
Vincent T Janmaat, Ewout W Steyerberg, Ate van der Gaast, Ron HJ Mathijssen, Marco J Bruno, Maikel P Peppelenbosch, Ernst J Kuipers & Manon CW Spaander. (2017) Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database of Systematic Reviews 2017:11.
Crossref
Anna Dorothea Wagner, Nicholas LX Syn, Markus Moehler, Wilfried Grothe, Wei Peng Yong, Bee-Choo Tai, Jingshan Ho & Susanne Unverzagt. (2017) Chemotherapy for advanced gastric cancer. Cochrane Database of Systematic Reviews 2017:8.
Crossref
Jinping Sun, Zheng Ren, Xinfang Sun, Hongtao Hou, Ke Li & Quanxing Ge. (2017) Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis. Oncotarget 8:24, pages 39673-39682.
Crossref
Emil ter Veer, Nadia Haj Mohammad, Gert van Valkenhoef, Lok Lam Ngai, Rosa M. A. Mali, Maarten C. Anderegg, Martijn G. H. van Oijen & Hanneke W. M. van Laarhoven. (2016) The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis. Journal of the National Cancer Institute 108:10, pages djw166.
Crossref
Emil ter Veer, Nadia Haj Mohammad, Paul Lodder, Lok Lam Ngai, Mary Samaan, Martijn G. H. van Oijen & Hanneke W. M. van Laarhoven. (2016) The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis. Gastric Cancer 19:3, pages 696-712.
Crossref
Jun Huang, Yongzhao Zhao, Yong Xu, Yanjie Zhu, Jiale Huang, Yanna Liu, Liying Zhao, Zhijia Li, Hao Liu, Qi-long Wang & Xiaolong Qi. (2016) Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials. Oncotarget 7:23, pages 34824-34831.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.